Search Results
Nov 17, 2025, 09:03 ET Mars Unwraps Holiday Cheer with Seasonal Treats from M&M'S® and TWIX®
multimedia:https://www.prnewswire.com/news-releases/mars-unwraps-holiday-cheer-with-seasonal-treats-from-mms-and-twix-302616452.html
More news about: Mars, Incorporated
Nov 14, 2025, 17:03 ET Micro Medical Solutions Expands Board of Directors with Appointment of Vince Burgess and John Dahldorf
amputations in patients with CLTI. The device is currently under Premarket Approval (PMA) review. About MMS Micro Medical Solutions (MMS) is an innovative medical device company addressing the critical unmet need in BTK arterial disease. Our technology is designed
More news about: Micro Medical Solutions
Nov 13, 2025, 09:10 ET Solutions by Text and Conduent Partner to Modernize Loan Servicing with Integrated, Compliant Text Messaging
growing demand for efficient, mobile-first communication and clear customer preference for text messaging. Integrating SBT's real-time, compliant SMS, MMS and RCS messaging capabilities into Conduent's automated loan servicing workflows will reduce resolution time for servicing issues, increase on-time
More news about: Solutions by Text
Nov 12, 2025, 11:03 ET LAFCO New York Partners with Listrak to Power e-Commerce Expansion of its "Pink Paradise" Collaboration with The Colony Hotel
to meet the customer where they want to shop. To generate excitement ahead of the launch, LAFCO and Listrak sent out communications on email, SMS and MMS channels at the end of September, announcing that the "Pink Paradise" collection is back by popular demand, with conversion rates exceeding 10 percent.
More news about: LISTRAK
Nov 10, 2025, 09:00 ET WidePoint Awarded Task Order Under the Navy Spiral 4 Contract Vehicle for the U.S. Army Valued at More than $1.25 Million
landscape. WidePoint is recognized for pioneering technology solutions that include Identity & Access Management (IAM), Mobility Managed Services (MMS), Telecom Management, Information Technology as a Service, Cloud Security, and Analytics & Billing as a Service (ABaaS). To learn more, visit
More news about: WidePoint Corporation
Nov 06, 2025, 06:30 ET BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
in MDS, MMS and PS. MDS performance reflects strong growth led by Vascular Access Management, partially offset by volume-based procurement in China. MMS performance
More news about: BD (Becton, Dickinson and Company)
Nov 05, 2025, 10:57 ET Late-Breaking Clinical Trial Results Announced at VIVA 2025
within 7 days and functional assessments (eg, PVFS Scale, mMRC, Borg Scale, 6MWT). Core lab parameters included pulmonary artery (PA) obstruction index (MMS and RMMS) and IVC reflux. Clinical parameters included vital signs and National Early Warning Score 2 score (risk of clinical deterioration). The
More news about: The VIVA Foundation
Nov 03, 2025, 13:24 ET Binding Heads of Term Reached With US Group to Joint Venture Disko-Nuussuaq Project, Greenland
mineralisation similar to the nickel/copper sulphide mine Norilsk-Talnakh located in northern Russia. Seven significant Magmatic Massive Sulphide ("MMS") targets have been identified to-date at the licence area, with the largest being confirmed now at 5.9 kilometres ("km") long by 1.1km wide. A 28
More news about: 80 Mile PLC
Oct 31, 2025, 16:25 ET SuperX Reports Annual Financial Results for FY2025; Sets Stage for AI Infrastructure Growth in FY2026
Next-Generation AI Servers: Launched a suite of next-generation AI servers, including the XN9160-B200 and XN9160-B300, and an All-in-One Multi-Model Server (MMS) series. Rack-Scale Platforms: Launched a new rack-scale AI platform powered by NVIDIA GB300
More news about: SuperX AI Technology Ltd
Oct 26, 2025, 15:00 ET Cristcot to Present Data on Novel Ulcerative Colitis Treatment at the American College of Gastroenterology 2025 Annual Meeting
achieved its primary endpoint of clinical remission at Day 29 and secondary endpoint of clinical response at Day 15, both using modified Mayo Score (MMS) criteria, demonstrating statistically significant improvements for patients treated with the ngHCA 90 mg suppository compared to those who received
More news about: Cristcot
Oct 24, 2025, 14:32 ET MM's Tristan Southard Named 2025 Top Lobbyist by National Institute for Lobbying & Ethics
standards set forth by NILE," said Brent Merchant, Co-founder and Partner at Merchant McIntyre & Associates. "The results Tristan has helped his and MM's clients achieve at the federal level are positively impacting thousands of lives nationwide." As Vice President of Legislative
More news about: Merchant McIntyre Associates
Oct 09, 2025, 13:49 ET M&M'S®とCrocs、限定コレクションを発表：ファッションと遊び心の融合
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg SOURCE Mars, Incorporated
More news about: Mars, Incorporated
Oct 09, 2025, 13:29 ET 엠앤엠즈®, 크록스와 함께 한정판 컬렉션 공개... 패션과 재미의 유쾌한 동행
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Oct 09, 2025, 13:19 ET M&M'S® 和 Crocs 推出限量版系列：巧妙融合時尚與趣味
View original content:https://www.prnewswire.com/apac/zh/news-releases/mms--crocs--302580079.html SOURCE Mars, Incorporated
More news about: Mars, Incorporated
Oct 08, 2025, 09:01 ET M&M'S® Pops with Brand's First-Ever Freeze-Dried Candy, M&M'S POP'd Caramel
multimedia:https://www.prnewswire.com/news-releases/mms-pops-with-brands-first-ever-freeze-dried-candy-mms-popd-caramel-302578094.html
More news about: Mars, Incorporated
Oct 03, 2025, 12:46 ET California Greens Equips Families for Stronger Immunity During Back-to-School Season
naturally support immunity. Reishi, Shiitake, and Maitake are three of the most common MMs in use in the nutraceutical and natural care markets, and Gardy includes a combination of all three. These mushrooms play a key
More news about: California Greens
Oct 01, 2025, 09:01 ET IT'S ALIVE! AGAIN! Mars Marks The Return Of M&M'S® Halloween Rescue Squad, To Make This Halloween The Most FUN Yet
multimedia:https://www.prnewswire.com/news-releases/its-alive-again-mars-marks-the-return-of-mms-halloween-rescue-squad-to-make-this-halloween-the-most-fun-yet-302571747.html
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® and Crocs Unveil Limited-Edition Collection: A Playful Fusion of Fashion and Fun
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® und Crocs stellen Kollektion in limitierter Auflage vor: Eine spielerische Fusion aus Mode und Spaß
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® y Crocs presentan una colección de edición limitada: una fusión lúdica de moda y diversión
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® et Crocs dévoilent une collection en édition limitée : Une fusion ludique de la mode et du plaisir
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® e Crocs revelam coleção de edição limitada: uma fusão divertida de moda e diversão
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® y Crocs presentan una colección de edición limitada: una divertida fusión de moda y diversión
https://mma.prnewswire.com/media/1973412/Mars_MMS_Logo.jpg
More news about: Mars, Incorporated
Sep 25, 2025, 09:00 ET M&M'S® and Crocs Unveil Limited-Edition Collection: A Playful Fusion of Fashion and Fun
multimedia:https://www.prnewswire.com/news-releases/mms-and-crocs-unveil-limited-edition-collection-a-playful-fusion-of-fashion-and-fun-302566281.html
More news about: Mars, Incorporated
Sep 19, 2025, 17:28 ET TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen
in vitro studies in an inflammatory monocyte model.2d) Moderately to severely active UC was defined as a modified Mayo score (mMS) between 5 and 9 and an centrally reviewed endoscopy (ES) score of 2 or 3.4e) Symptomatic response is defined as a decrease in
More news about: Johnson & Johnson